Toggle navigation
Home
Search
Services
Blog
Contact
About
Biology of Cytokine-Induced Killer Cells
Lu, Peggy P.
Stanford University, Stanford, CA, United States
Search 8 grants from Peggy Lu
Search grants from Stanford University
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Role of AT1 cells in perinatal lung maturation
Prognostic Impact and Arrhythmic Potential of Peri-infarct Zone by Cardiac MRI
Age and Gender Differences in Apoptosis and Stem Cells
Regulation of Cell Division in the Developing Retina
Assessment of Treatment Services for Marijuana Users
Recently added grants:
TGF beta - Regulated EMT
Cancer prevention and treatment by activation of a brain-adipocyte axis
The Role of Ribosomal Proteins in the P53-MDM2 Pathway
Mcl-1/Bfl-1 in apoptosis and signal transduction: a structure/function approach
Integration of Genomic and Clinical Data to Enhance Subtyping of Colon Cancer
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
1F32CA009324-01
Application #
2085279
Study Section
Immunology, Virology, and Pathology Study Section (IVP)
Project Start
1993-04-01
Project End
Budget Start
1993-01-01
Budget End
1993-12-31
Support Year
1
Fiscal Year
1992
Total Cost
Indirect Cost
Institution
Name
Stanford University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
800771545
City
Stanford
State
CA
Country
United States
Zip Code
94305
Related projects
NIH 1994
F32 CA
Biology of Cytokine-Induced Killer Cells
Lu, Peggy P. / Stanford University
NIH 1992
F32 CA
Biology of Cytokine-Induced Killer Cells
Lu, Peggy P. / Stanford University
Publications
Lu, P H; Negrin, R S
(1994)
A novel population of expanded human CD3+CD56+ cells derived from T cells with potent in vivo antitumor activity in mice with severe combined immunodeficiency.
J Immunol 153:1687-96
Comments
Be the first to comment on this grant